LifeMD, Inc. (LFMD)
Market Cap | 64.16M |
Revenue (ttm) | 118.33M |
Net Income (ttm) | -54.91M |
Shares Out | 31.45M |
EPS (ttm) | -1.80 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 24,306 |
Open | 1.98 |
Previous Close | 1.98 |
Day's Range | 1.97 - 2.04 |
52-Week Range | 1.72 - 4.32 |
Beta | 1.35 |
Analysts | Buy |
Price Target | 8.16 (+300.0%) |
Earnings Date | Mar 6, 2023 |
About LFMD
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair lo... [Read more]
Financial Performance
In 2021, LifeMD's revenue was $92.88 million, an increase of 149.04% compared to the previous year's $37.29 million. Losses were -$61.77 million, -2.52% less than in 2020.
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for LFMD stock is "Buy." The 12-month stock price forecast is $8.16, which is an increase of 300.00% from the latest price.
News

LifeMD Appoints Jessica Friedeman as Chief Marketing Officer to Support the Company's Rapid Expansion into Virtual Primary Care
NEW YORK, Jan. 04, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced the appointment of Jessica Friedeman as Chief Marketing Officer...

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, Dec. 27, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD/LFMDP), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividen...

LifeMD, Inc. to Participate in Upcoming Investor Conferences
NEW YORK, Nov. 18, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that LifeMD management will participate in the following upcomi...

LifeMD, Inc. (LFMD) Reports Q3 Loss, Misses Revenue Estimates
LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of 88.89% and 2.42%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

LifeMD, Inc. Reports Third Quarter 2022 Results
NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, reported results for the third quarter ended September 30, 2022. All figure com...

LifeMD and Cleared Offer New Hope to Allergy Patients Through Strategic Partnership With Allergenis
Strategic partnership enables direct-to-consumer food allergy clinic to provide convenient access to crucial peanut allergy threshold information Strategic partnership enables direct-to-consumer food ...

LifeMD, Inc. Reports Second Quarter 2022 Results
NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, reported results for the second quarter ended June 30, 2022. All figure compari...

LifeMD, Inc. to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 11, 2022
NEW YORK, July 27, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced that it will report its financial results for the secon...

LifeMD, Inc. (LFMD) Upgraded to Buy: Here's Why
LifeMD, Inc. (LFMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

LifeMD, Inc. (LFMD) Reports Q1 Loss, Misses Revenue Estimates
LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of 3.85% and 6.43%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

LifeMD, Inc. Reports First Quarter 2022 Results
NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, reported results for the first quarter ended March 31, 2022. All figure comparis...

LifeMD to Participate in the Upcoming May Conferences
NEW YORK, April 28, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that that management will participate in the following upcomin...

LifeMD to Participate in the 21st Annual Needham Virtual Healthcare Conference
NEW YORK, April 07, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that that management will participate in the 21st Annual Needh...

LifeMD Launches Proprietary Over-the-Counter Skincare Line for Women, Expanding Teledermatology Offerings
NavaMD's clinically studied, OTC skincare platform is protected by a global intellectual property portfolio and $50+ Million of third-party capital invested in R&D, clinical research, and manufacturin...

LifeMD, Inc. (LFMD) Reports Q4 Loss, Misses Revenue Estimates
LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of 25.64% and 0.11%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

LifeMD Reports Fourth Quarter and Full Year 2021 Results
NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, reported results for the fourth quarter and year ended December 31, 2021. All ...

LifeMD to Host 2022 Virtual Analyst and Investor Day
Presentations to Highlight Primary Care Technology Platform, Recently Acquired Allergy, Asthma & Immunology Business, and Details on 2022 Revenue Mix and Growth Strategy Presentations to Highlight Pri...

LifeMD to Participate in the Upcoming February Investor Conferences
NEW YORK, Jan. 27, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (the “Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that management will participate in the SVB Lee...

3 Medical Services Stocks to Buy Despite Near-Term Industry Woes
The Zacks Medical - Services industry is growing on digital healthcare adoption. AMN, AMEH and LFMD are set to gain the most.

LifeMD Expands Patient Offerings by Acquiring Leading Allergy Telehealth Platform
Acquisition of Cleared Further Diversifies LifeMD's Telehealth Offerings to Encompass Allergy, Asthma, and Immunology

LifeMD to Participate in Panel Presentation at LifeSci Partners Corporate Access Event 2022
CEO Schreiber to discuss changes made possible via proprietary virtual care platforms CEO Schreiber to discuss changes made possible via proprietary virtual care platforms

LifeMD to Participate in Upcoming January Investor Conferences
NEW YORK, Dec. 30, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (the “Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that management will participate in the followi...

LifeMD to Participate in the Stephens Annual Investment Conference
NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD) today announced that management will present at the Stephens Annual Investment Conference on Monday, November...

LifeMD, Inc. (LFMD) Reports Q3 Loss, Tops Revenue Estimates
LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of 26.53% and 1.62%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

LifeMD to Release Third Quarter 2021 Financial Results on Wednesday, November 10, 2021
Hosted conference call to begin at 5:00 p.m. ET Hosted conference call to begin at 5:00 p.m. ET